Related Experiment Video
Updated: Aug 18, 2025
09:35
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
14.3K
Gene therapy for hemophilia
1Department of Haematology, UCL Cancer Institute, London, UK.
Hematology. American Society of Hematology. Education Program
|December 9, 2022
Summary
Gene therapy offers a new era for hemophilia treatment, with approved products for hemophilia A and B. This one-time treatment uses adeno-associated virus vectors to enable continuous factor production, showing sustained benefits and manageable side effects.
Area of Science:
- Hematology
- Molecular Biology
- Gene Therapy
Background:
- Hemophilia A and B treatments have advanced from molecular diagnostics to recombinant therapies.
- Gene therapy represents the next frontier, with regulatory approvals imminent.
Approach:
- Utilizes genetically modified adeno-associated virus (AAV) vectors for gene delivery.
- Targets hepatocytes in the liver to produce endogenous coagulation factors (FVIII or FIX).
- Involves a single infusion for sustained therapeutic effect.
Key Points:
- Valoctocogene roxaparvovec (hemophilia A) and etranacogene dezaparvovec (hemophilia B) are leading gene therapies.
- Gene therapy demonstrates sustained clinical benefits exceeding 5 years post-administration.
- Commonly observed side effect is a self-limiting, immune-mediated rise in alanine aminotransferase, manageable with immunosuppression.
Conclusions:
- Gene therapy heralds a new paradigm in hemophilia management.
- Ongoing research and development are crucial for widespread adoption.
- Long-term safety and efficacy are supported by current observational data.
Related Concept Videos
00:59Gene Therapy
25.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
827
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827
01:59CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
00:49What is Genetic Engineering?
74.6K
Overview
74.6K
01:24Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
01:29Microorganisms in Medicine and Therapeutics
162
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
162